Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Clinicopathological implications of mitochondrial genome alterations in pediatric acute myeloid leukemia

: Kang, Min-Gu; Kim, Yu-Na; Lee, Jun Hyung; Szardenings, Michael; Baek, Hee-Jo; Kook, Hoon; Kim, Hye-Ran; Shin, Myung Geun

Fulltext (PDF; )

Annals of laboratory medicine : alm 36 (2016), No.2, pp.101-110
ISSN: 2234-3814 (Online)
ISSN: 2234-3806 (Print)
Journal Article, Electronic Publication
Fraunhofer IZI ()
pediatric; acute myeloid leukemia; clinical outcomes; mtDNA; copy number; 4,977-bp deletion

Background: To the best of our knowledge, the association between pediatric AML and mitochondrial aberrations has not been studied. We investigated various mitochondrial aberrations in pediatric AML and evaluated their impact on clinical outcomes.
Methods: Sequencing, mitochondrial DNA (mtDNA) copy number determination, mtDNA 4,977-bp large deletion assessments, and gene scan analyses were performed on the bone marrow mononuclear cells of 55 pediatric AML patients and on the peripheral blood mononuclear cells of 55 normal controls. Changes in the mitochondrial mass, mitochondrial membrane potential, and intracellular reactive oxygen species (ROS) levels were also examined.
Results: mtDNA copy numbers were about two-fold higher in pediatric AML cells than in controls (P<0.0001). Furthermore, a close relationship was found between mtDNA copy number tertiles and the risk of pediatric AML. Intracellular ROS levels, mitochondrial mass, and mitochondrial membrane potentials were all elevated in pediatric AML. The frequency of the mtDNA 4,977-bp large deletion was significantly higher (P<0.01) in pediatric AML cells, and pediatric AML patients harboring high amount of mtDNA 4,977-bp deletions showed shorter overall survival and event-free survival rates, albeit without statistical significance.
Conclusions: The present findings demonstrate an association between mitochondrial genome alterations and the risk of pediatric AML.